Alnylam Pharma Q4 Loss Narrowed - Quick Facts

By RTT News, 
A A A
Share |


(RTTNews.com) - Alnylam Pharmaceuticals, Inc. ( ALNY ) Thursday said fourth-quarter loss narrowed to $32.4 million or $0.51 per share from $62.2 million or $1.20 per share in the same period last year.

On average, seven analysts polled by Thomson Reuters expected the company to reported report a loss of $0.45 per share for the quarter. Analysts' estimates typically exclude special items.

Revenues improved to $10.8 million from $8.5 million last year. Analysts expected revenues of $9.98 million.

For comments and feedback: contact editorial@rttnews.com

http://www.rttnews.com



This article appears in: News Headlines

Referenced Stocks: ALNY , TRI

RTT News


More from RTT News:

Related Videos

Stocks

Referenced

Most Active by Volume

74,972,696
  • $16.29 ▲ 1.24%
58,110,176
  • $63.0301 ▲ 2.92%
52,113,540
  • $4.30 ▲ 4.37%
45,053,607
  • $26.18 ▲ 3.40%
40,556,519
  • $3.22 ▲ 0.94%
33,697,770
  • $50.83 ▲ 1.90%
33,642,638
  • $4.56 ▲ 2.01%
31,530,460
  • $20.06 ▲ 11.88%
As of 4/22/2014, 04:07 PM